HIGHLIGHTS
- who: Hongshan Li from the Institute of Liver Disease, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China have published the paper: Gypenosides regulate farnesoid X receptor-mediated bile acid and lipid metabolism in a mouse model of non-alcoholic steatohepatitis, in the Journal: (JOURNAL)
- what: Hepatic fibrosis and non-alcoholic steatohepatitis (NASH) are among the main reasons for the development of liver cirrhosis and hepatocellular carcinoma . The authors aimed to explore possible crosstalk between Gyp and the FXR-mediated lipid and bile acid metabolic pathways.
- how: One-way analysis of variance . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.